236 related articles for article (PubMed ID: 16518755)
1. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.
Ergonul O; Tuncbilek S; Baykam N; Celikbas A; Dokuzoguz B
J Infect Dis; 2006 Apr; 193(7):941-4. PubMed ID: 16518755
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels in Crimean-Congo hemorrhagic fever.
Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
[TBL] [Abstract][Full Text] [Related]
3. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever.
Kaya S; Elaldi N; Kubar A; Gursoy N; Yilmaz M; Karakus G; Gunes T; Polat Z; Gozel MG; Engin A; Dokmetas I; Bakir M; Yilmaz N; Sencan M
BMC Infect Dis; 2014 Jul; 14():416. PubMed ID: 25066751
[TBL] [Abstract][Full Text] [Related]
4. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
[TBL] [Abstract][Full Text] [Related]
6. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses?
Ozsurekci Y; Arasli M; Karadag Oncel E; Caglayik DY; Kaya A; Icagasioglu FD; Engin A; Korukluoglu G; Elaldi N; Ceyhan M
J Med Virol; 2013 Nov; 85(11):1955-9. PubMed ID: 23893846
[TBL] [Abstract][Full Text] [Related]
7. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.
Akinci E; Yilmaz M; Bodur H; Ongürü P; Bayazit FN; Erbay A; Ozet G
Int J Infect Dis; 2009 Sep; 13(5):560-3. PubMed ID: 19112036
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.
Burt FJ; Swanepoel R; Shieh WJ; Smith JF; Leman PA; Greer PW; Coffield LM; Rollin PE; Ksiazek TG; Peters CJ; Zaki SR
Arch Pathol Lab Med; 1997 Aug; 121(8):839-46. PubMed ID: 9278612
[TBL] [Abstract][Full Text] [Related]
9. [Elevated levels of cytokines in plasma from patients with disseminated intravascular coagulation].
Wada H; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T; Kageyama S; Kobayashi T
Rinsho Ketsueki; 1990 Oct; 31(10):1622-5. PubMed ID: 2255053
[TBL] [Abstract][Full Text] [Related]
10. The frequency of self-reported allergic diseases in patients with crimean-congo haemorrhagic fever.
Abadoglu O; Engin A
Allergol Immunopathol (Madr); 2009; 37(5):234-8. PubMed ID: 19775796
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them].
Yu LN; Yang XS; Hua Z; Xie W
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):469-71. PubMed ID: 19567096
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.
Yilmaz M; Aydin K; Akdogan E; Sucu N; Sonmez M; Omay SB; Koksal I
J Clin Virol; 2008 Aug; 42(4):415-7. PubMed ID: 18434247
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
Simpson AJ; Smith MD; Weverling GJ; Suputtamongkol Y; Angus BJ; Chaowagul W; White NJ; van Deventer SJ; Prins JM
J Infect Dis; 2000 Feb; 181(2):621-5. PubMed ID: 10669346
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
15. [Respiratory lesions in Congo-Crimean hemorrhagic fever].
Sannikova IV; Pacechnikov VD; Maleev VV
Ter Arkh; 2007; 79(11):20-3. PubMed ID: 18219967
[TBL] [Abstract][Full Text] [Related]
16. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
[TBL] [Abstract][Full Text] [Related]
17. Cytokine response in crimean-congo hemorrhagic fever virus infection.
Ergönül Ö; Şeref C; Eren Ş; Çelikbaş A; Baykam N; Dokuzoğuz B; Gönen M; Can F
J Med Virol; 2017 Oct; 89(10):1707-1713. PubMed ID: 28547808
[TBL] [Abstract][Full Text] [Related]
18. [Alteration in serum cytokines of patients with multiple organ dysfunction syndrome after liver transplantation].
Shen ZY; Liu YH; Wang Y; Liu L; Ming Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):28-30. PubMed ID: 17207361
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
[TBL] [Abstract][Full Text] [Related]
20. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever.
Sonmez M; Aydin K; Durmus A; Sucu N; Yilmaz M; Akdogan E; Koksal I; Ovali E; Omay SB
J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
